Might be a good time to return and post some of my thoughts... About in line with what (IMO) was obvious 6 months ago.
- You can't sell product without additional expenses (TXMD)
- You can't quickly turn around diminishing sales for a product (TXMD)
- You can't rapidly increase sales and exposure for new products (Nextstellis)
There is danger in the MYX numbers -
- Women's division revenue is terrible!!!!!
- TXMD performance must have been terrible if "$61.9m was driven primarily by an increase in sales of NEXSTELLIS"
- IMO impairments are heading for a crash. Massive crash. BIG OUCHIES!
WTF:
How can we value TXMD at $363m ?!?!?!? Where are the sales!!!!! Where are the margins promised!!!!! These products have been in the books for 6 months and should have been tracking at ~$40m usd
Mayne overpaid again. Or - just have a terrible sales force that can't even maintain the momentum of existing products.
There numbers are devastating:
Unfortunately the promised recovery of Derm hasn't eventuated eitherThese are terrible numbers and you'd have to question whether it is worth maintaining the products on the book. Revenue tanking. Contributing negative. If they can get some $$ - might be worth taking it.
All in all - VERY disappointing results as the sales of Woman's products are just not anywhere near where they need to be. There will have to be significant cost cutting to get into positive territory with the lack of growth.
But ......... The forward looking statement. If this is to be believed, there is a light - just need another 6 months to see if the sales can be accelerated.
Man I'm getting too old to be holding shares like MayneDYOR and good luck.
- Forums
- ASX - By Stock
- Ann: 2023 Full Year Results Investor Presentation
Might be a good time to return and post some of my thoughts......
-
- There are more pages in this discussion • 25 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MYX (ASX) to my watchlist
|
|||||
Last
$5.25 |
Change
0.060(1.16%) |
Mkt cap ! $446.6M |
Open | High | Low | Value | Volume |
$5.16 | $5.27 | $5.05 | $1.936M | 373.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1150 | $5.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$5.27 | 4150 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 2400 | 5.170 |
1 | 2400 | 5.110 |
1 | 196 | 5.100 |
1 | 907 | 5.070 |
3 | 13125 | 5.050 |
Price($) | Vol. | No. |
---|---|---|
5.270 | 3000 | 1 |
5.290 | 5000 | 1 |
5.300 | 5000 | 1 |
5.310 | 4000 | 1 |
5.340 | 5000 | 1 |
Last trade - 16.10pm 30/08/2024 (20 minute delay) ? |
Featured News
MYX (ASX) Chart |
The Watchlist
CCO
THE CALMER CO INTERNATIONAL LIMITED
Anthony Noble, MD & CEO
Anthony Noble
MD & CEO
Previous Video
Next Video
SPONSORED BY The Market Online